U.S. Markets close in 6 hrs 11 mins

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.5200+0.0100 (+0.28%)
As of 09:45AM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 315.1000
52 Week Low 33.2900
50-Day Moving Average 33.7844
200-Day Moving Average 34.7804

Share Statistics

Avg Vol (3 month) 363.82k
Avg Vol (10 day) 398.84k
Shares Outstanding 517.23M
Implied Shares Outstanding 6N/A
Float 86.48M
% Held by Insiders 140.25%
% Held by Institutions 119.81%
Shares Short (Sep 14, 2021) 4107.54k
Short Ratio (Sep 14, 2021) 40.49
Short % of Float (Sep 14, 2021) 41.10%
Short % of Shares Outstanding (Sep 14, 2021) 40.80%
Shares Short (prior month Aug 12, 2021) 443.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-16.00%
Return on Equity (ttm)-36.31%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-4.74M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35.8M
Total Cash Per Share (mrq)2.67
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)31.42
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-7.77M
Levered Free Cash Flow (ttm)-7.15M